mhurhangee/ep-ind-claims huggingface dataset:
A process for catalytic fast pyrolysis of biomass comprising: a) performing a catalytic fast pyrolysis process on biomass to provide a first vapor phase stream comprising, on a water-free and solids-free basis, from 25 to 80 % wt CO, at least 15 % wt CO 2, from 0.2 to 10% wt H 2, and a compound selected from the group consisting of methane, ethane, ethylene, propane, propylene, butanes, butenes, pentanes, pentenes, aromatics including phenols, cresols, naphthalenes and indole; and combinations thereof; b) mixing the first vapor phase stream of step a) with solvent having an absorption capacity for CO 2 that is at least 5 times, or at least 10 times, the absorption capacity of the solvent for CO to make a mixed phase stream, and c) separating the mixed phase stream of step b) into a second vapor phase stream comprising CO and a liquid phase stream, wherein said second vapor phase stream of step c) has a higher concentration of CO and a lower concentration of CO 2 than the first vapor phase stream of step a), and thereby recovering the CO. a) performing a catalytic fast pyrolysis process on biomass to provide a first vapor phase stream comprising, on a water-free and solids-free basis, from 25 to 80 % wt CO, at least 15 % wt CO 2, from 0.2 to 10% wt H 2, and a compound selected from the group consisting of methane, ethane, ethylene, propane, propylene, butanes, butenes, pentanes, pentenes, aromatics including phenols, cresols, naphthalenes and indole; and combinations thereof; b) mixing the first vapor phase stream of step a) with solvent having an absorption capacity for CO 2 that is at least 5 times, or at least 10 times, the absorption capacity of the solvent for CO to make a mixed phase stream, and c) separating the mixed phase stream of step b) into a second vapor phase stream comprising CO and a liquid phase stream, wherein said second vapor phase stream of step c) has a higher concentration of CO and a lower concentration of CO 2 than the first vapor phase stream of step a), and thereby recovering the CO.
Rail vehicle having an air-conditioning system which has a refrigeration circuit, which comprises an inner heat exchanger, wherein the inner heat exchanger is connected in terms of air-conditioning to an outer heat exchanger which is arranged within a flow channel which extends in the longitudinal direction of the rail vehicle and can be arranged beyond the outer skin thereof, characterized in that the flow channel and the outer heat exchanger form a movable constructional unit which can be adjusted between a retracted position and an extended position, in which the flow channel protrudes from the adjacent outer skin region.
A device for capturing an obstruction in a vasculature comprising a first elongated member comprising a lumen therethrough, a proximal end, and a distal end; an expandable element positioned near the distal end of the first elongated member, the expandable element expandable between a collapsed delivery configuration and an expanded configuration; an invertible element, the invertible element positioned near the distal end of the first elongated member, the invertible element expandable between a collapsed delivery configuration and an expanded configuration, the invertible element invertible between the expanded configuration and an inverted configuration, the inverted configuration forming a pocket; a gap positioned between the expandable element and the invertible element, the gap sized to place across the obstruction; and a core wire comprising a distal end and a proximal end, wherein the first elongated member is concentric with the core wire and the core wire is positioned at the axis of the first elongated member, characterized in that the expandable element is joined to the core wire at a distal joint and joined to the first elongated member at a proximal joint such that a movement of the core wire proximally in relation to the first elongated member expands the expandable element, the device further comprising a distal coil, and the distal coil positioned near the distal end of the core wire and connected to the core wire. a first elongated member comprising a lumen therethrough, a proximal end, and a distal end; an expandable element positioned near the distal end of the first elongated member, the expandable element expandable between a collapsed delivery configuration and an expanded configuration; an invertible element, the invertible element positioned near the distal end of the first elongated member, the invertible element expandable between a collapsed delivery configuration and an expanded configuration, the invertible element invertible between the expanded configuration and an inverted configuration, the inverted configuration forming a pocket; a gap positioned between the expandable element and the invertible element, the gap sized to place across the obstruction; and a core wire comprising a distal end and a proximal end, wherein the first elongated member is concentric with the core wire and the core wire is positioned at the axis of the first elongated member, characterized in that the expandable element is joined to the core wire at a distal joint and joined to the first elongated member at a proximal joint such that a movement of the core wire proximally in relation to the first elongated member expands the expandable element, the device further comprising a distal coil, and the distal coil positioned near the distal end of the core wire and connected to the core wire.
A vaccine composition for use in a method of preventing and/or ameliorating Norovirus infection or Norovirus induced illness and/or reducing at least one symptom of a Norovirus infection or illness, wherein the method induces at least a three-fold increase in Norovirus-specific serum antibody titer in a human as compared to the titer in the human prior to administration of the composition, the method comprising administering parenterally to the human no more than a single dose of the vaccine composition, said composition comprising 15 μg to 50ug of genogroup I Norovirus virus-like particles (VLPs) and 50 μg to 150 μg of genogroup II Norovirus VLPs, wherein said genogroup I Norovirus VLPs comprise a capsid protein from a genogroup I viral strain and wherein said genogroup II Norovirus VLPs comprise a capsid protein from a genogroup II viral strain, wherein said composition further comprises the adjuvants monophosphoryl lipid A and aluminum hydroxide.
Electrical switching device for medium or high voltage circuits having at least a nominal contact arrangement, wherein the nominal contact arrangement comprises a) at least a first nominal contact comprising a plurality of contact fingers (6, 7) forming a finger cage concentric with respect to a longitudinal axis (z), wherein the contact fingers (6, 7) are separated from one another by empty slots (10, 8) extending up to a free end of the contact fingers (6, 7), and b) at least a mating second nominal contact, wherein at least one of the nominal contacts (6, 7; 3b) is movable parallel to the longitudinal axis (z) and cooperates with the other nominal contact (3b; 6, 7) for closing and opening the electric switching device, characterized in that the empty slots comprise first and second empty slots (10, 8), wherein the second empty slots are shorter than the first empty slots, and wherein the contact fingers (6, 7) are grouped in groups, with the contact fingers (6, 7) of each group being separated by the second empty slots and the contact fingers (6, 7) of adjacent groups being separated by the first empty slots. a) at least a first nominal contact comprising a plurality of contact fingers (6, 7) forming a finger cage concentric with respect to a longitudinal axis (z), wherein the contact fingers (6, 7) are separated from one another by empty slots (10, 8) extending up to a free end of the contact fingers (6, 7), and b) at least a mating second nominal contact,
A liquid distributor, comprising a channel for the reception of a liquid, which is divided by a dividing wall into a first chamber and into a second chamber, wherein an inlet element for a liquid opens into the first chamber so that the first chamber can be filled with the liquid, with the first chamber being connected to the second chamber via openings (7, 8) which are applied in the dividing wall so that the liquid can be distributed from the first chamber via the openings into the second chamber, wherein the first chamber is arranged next to the second chamber and the dividing wall extends in the longitudinal direction of the channel, wherein the channel has a base, with the base of the channel having outlet openings for the discharge of the liquid in the region of the second chamber, characterized in that the area of the openings (7, 8) in the dividing wall amounts to a maximum of 30%, wherein the dividing wall comprises at least one vertical section and the channel has a channel width, with the first chamber having a chamber width which is defined by the spacing between the dividing wall and the side wall of the channel and with the chamber width of the first chamber being smaller than the channel width, with the chamber width being smaller than the calming path of the liquid flow.
A method for providing an ECPR master electrode, comprising the step of: providing a circular carrier element having an electrically conducting electrode surface on a back side and a topographical pattern defining a plurality of electrochemical cells in the carrier element on a front side thereof, each electrochemical cell comprising a side wall and a bottom, wherein the planar surface extending between two adjacent electrochemical cells is covered by an electrically insulating layer and wherein the bottom has an electrically conductive surface being conductively connected to the electrically conducting electrode surface on the back side through the carrier element, wherein the step of providing said topographical pattern comprises: - passivating a peripheral part of the front side of the carrier element for forming an isolation region, said isolation region surrounding a circular device area; - providing a patterned dielectric hardmask layer across said device area and said isolation region; and - etching the carrier element such that said electrochemical cells are formed at the device area, wherein the passivation of the isolation region further prevents the formation of electrochemical cells by etching at said isolation region. providing a circular carrier element having an electrically conducting electrode surface on a back side and a topographical pattern defining a plurality of electrochemical cells in the carrier element on a front side thereof, each electrochemical cell comprising a side wall and a bottom, wherein the planar surface extending between two adjacent electrochemical cells is covered by an electrically insulating layer and wherein the bottom has an electrically conductive surface being conductively connected to the electrically conducting electrode surface on the back side through the carrier element, wherein the step of providing said topographical pattern comprises: - passivating a peripheral part of the front side of the carrier element for forming an isolation region, said isolation region surrounding a circular device area; - providing a patterned dielectric hardmask layer across said device area and said isolation region; and - etching the carrier element such that said electrochemical cells are formed at the device area, wherein the passivation of the isolation region further prevents the formation of electrochemical cells by etching at said isolation region. - passivating a peripheral part of the front side of the carrier element for forming an isolation region, said isolation region surrounding a circular device area; - providing a patterned dielectric hardmask layer across said device area and said isolation region; and - etching the carrier element such that said electrochemical cells are formed at the device area, wherein the passivation of the isolation region further prevents the formation of electrochemical cells by etching at said isolation region.
An optoelectronic sensor, in particular a light grid, having a transmission unit and having a reception unit that comprise a plurality of individual light transmitters and a transmission control for the activation of the individual light transmitters, as well as a number of individual light receivers corresponding to the individual light transmitters and a receiver control connected to the individual light receivers, wherein, for object detection through an interruption of a light beam from an individual light transmitter to an associated individual light receiver, in a respective one individual beam evaluation time window, the individual light transmitters can be activated one after the other by the transmission control for the transmission of a transmission signal and the associated individual light receivers can be activated one after the other by the receiver control for the reception of the transmission signal, wherein the transmission control is configured to select at least one individual beam evaluation time window as a test time window in a scanning period having a plurality of consecutive individual beam evaluation time windows and to transmit the transmission signal changed in that in the test time window a transmission pattern of the transmission signal is changed, characterized in that groups of individual light transmitters and associated individual light receivers are formed in the transmission control and in the receiver control and in that the transmission control is configured to randomly select the at least one test time window, wherein a group is respectively selected in a scanning period and the at least one test time window can be selected randomly only with regard to one group in such a way that only the transmission signal of one individual light transmitter of the selected group can be changed, wherein the selection of one group for a scanning period takes place with reference to a deterministic sequence known in the transmission control and in the receiver control.
Chiral Iodonium ylide analogs having the formula: (referred to as iodonium ylide analogs A) wherein: R 1 = R 2 = R 3 = OCOOC(CH 3) 3, or R 1 = R 2 = OCOOC(CH 3) 3, OCH 3 and R 3 = COCH 3, COOCH 2 Ph, or R 1 = H; R 2 = OCOOC(CH 3) 3, OCH 3 and R 3 = COCH 3, COOCH 2 Ph, or R 1 = OCOOC(CH 3) 3, OCH 3; R 2 = H and R 3 = COCH 3, COOCH 2 Ph, and X = CH 2, O, S, NCH 3, NCH 2 Ph and Y = CH 2, C(CH 3) 2, =O or (referred to as iodonium ylide analogs B) or (referred to as iodonium ylide analogs C) wherein: R 1 = R 2 = OCH 2 Ph, OCOOC(CH 3) 3, OCH 3, or R1 = H and R 2 = OCH 2 Ph, OCOOC(CH 3) 3, OCH 3, or R 1 = OCH 2 Ph, OCOOC(CH 3) 3, OCH 3 and R 2 = H and X = CH 2, O, S, NCH 3, NCH 2 Ph Y = CH 2, C(CH 3) 2, =O R 1 = R 2 = R 3 = OCOOC(CH 3) 3, or R 1 = R 2 = OCOOC(CH 3) 3, OCH 3 and R 3 = COCH 3, COOCH 2 Ph, or R 1 = H; R 2 = OCOOC(CH 3) 3, OCH 3 and R 3 = COCH 3, COOCH 2 Ph, or R 1 = OCOOC(CH 3) 3, OCH 3; R 2 = H and R 3 = COCH 3, COOCH 2 Ph, and X = CH 2, O, S, NCH 3, NCH 2 Ph and Y = CH 2, C(CH 3) 2, =O or (referred to as iodonium ylide analogs B) or (referred to as iodonium ylide analogs C) wherein: R 1 = R 2 = OCH 2 Ph, OCOOC(CH 3) 3, OCH 3, or R1 = H and R 2 = OCH 2 Ph, OCOOC(CH 3) 3, OCH 3, or R 1 = OCH 2 Ph, OCOOC(CH 3) 3, OCH 3 and R 2 = H and X = CH 2, O, S, NCH 3, NCH 2 Ph Y = CH 2, C(CH 3) 2, =O R 1 = R 2 = OCH 2 Ph, OCOOC(CH 3) 3, OCH 3, or R1 = H and R 2 = OCH 2 Ph, OCOOC(CH 3) 3, OCH 3, or R 1 = OCH 2 Ph, OCOOC(CH 3) 3, OCH 3 and R 2 = H and X = CH 2, O, S, NCH 3, NCH 2 Ph Y = CH 2, C(CH 3) 2, =O
An imaging system (200, 200A, 200P, 200E, 300, 200F), comprising: a first illuminator (250, 250A, 250E, 250A, 250F) that irradiates a subject (SP, TG) with light whose intensity varies over time; and a first imaging device (100, 100A) that comprises a first imaging cell (10, 10A, 50) having a variable sensitivity, and a first sensitivity control line (82, 82A) electrically connected to the first imaging cell, wherein the first imaging cell comprises a photoelectron conversion area (12, 12cA) that receives the light from the subject to generate a signal charge, and a signal detection circuit (14, 14G) that detects the signal charge, during an exposure period from a reset of the first imaging cell until a readout of the signal charge accumulated in the first imaging cell by exposure, the first sensitivity control line supplies to the first imaging cell a first sensitivity control signal having a periodic waveform expressed by a first function that takes only positive values by adding a first constant to one basis from among bases of a system of functions constituting an orthogonal system; characterized in that the photoelectron conversion area includes: - a first electrode; - a translucent second electrode connected to the first sensitivity control line; and - a photoelectric conversion layer disposed between the first electrode and the second electrode. a first illuminator (250, 250A, 250E, 250A, 250F) that irradiates a subject (SP, TG) with light whose intensity varies over time; and a first imaging device (100, 100A) that comprises a first imaging cell (10, 10A, 50) having a variable sensitivity, and a first sensitivity control line (82, 82A) electrically connected to the first imaging cell, wherein the first imaging cell comprises a photoelectron conversion area (12, 12cA) that receives the light from the subject to generate a signal charge, and a signal detection circuit (14, 14G) that detects the signal charge, during an exposure period from a reset of the first imaging cell until a readout of the signal charge accumulated in the first imaging cell by exposure, the first sensitivity control line supplies to the first imaging cell a first sensitivity control signal having a periodic waveform expressed by a first function that takes only positive values by adding a first constant to one basis from among bases of a system of functions constituting an orthogonal system; characterized in that the photoelectron conversion area includes: - a first electrode; - a translucent second electrode connected to the first sensitivity control line; and - a photoelectric conversion layer disposed between the first electrode and the second electrode. - a first electrode; - a translucent second electrode connected to the first sensitivity control line; and - a photoelectric conversion layer disposed between the first electrode and the second electrode.
A process for making a polyether, comprising a) polymerizing one or more alkylene oxides at a temperature of 80 to 200°C in the presence of at least one polyhydric initiator compound and an alkylene oxide polymerization catalyst to produce a polyether mixture containing polyether polyol molecules and unsaturated polyether monols having a hydroxyl group at an end of a polyether chain; and b) reacting the polyether mixture with a thiol compound having at least 2 thiol groups, to convert at least a portion of the unsaturated polyether monols to coupled polyethers linked by a residue, after removal of thiol hydrogens, of the thiol compound. a) polymerizing one or more alkylene oxides at a temperature of 80 to 200°C in the presence of at least one polyhydric initiator compound and an alkylene oxide polymerization catalyst to produce a polyether mixture containing polyether polyol molecules and unsaturated polyether monols having a hydroxyl group at an end of a polyether chain; and b) reacting the polyether mixture with a thiol compound having at least 2 thiol groups, to convert at least a portion of the unsaturated polyether monols to coupled polyethers linked by a residue, after removal of thiol hydrogens, of the thiol compound.
An optoelectronic device (10; 70; 80) comprising: a substrate; pads on a surface of the substrate; semiconductor elements (24; 82), each element resting on a pad; a portion covering at least the lateral sides of each pad, said portion preventing the growth of the semiconductor elements on the lateral sides; and further characterized by a dielectric region extending in the substrate from said surface and connecting, for each pair of pads, one of the pads in the pair to the other pad in the pair. a substrate; pads on a surface of the substrate; semiconductor elements (24; 82), each element resting on a pad; a portion covering at least the lateral sides of each pad, said portion preventing the growth of the semiconductor elements on the lateral sides; and further characterized by a dielectric region extending in the substrate from said surface and connecting, for each pair of pads, one of the pads in the pair to the other pad in the pair.
Coating composition comprising (a) at least one hydroxyl-containing compound, (b) at least one compound having free and/or blocked isocyanate groups, and (c) at least one phosphorus-containing catalyst for the crosslinking of silane groups, (d) at least one further catalyst, one or more constituents of the coating composition containing hydrolyzable silane groups, characterized in that the catalyst is a bicyclic amine and the catalyst is 1,5-diazabicyclo[4.3.0]non-5-ene or 1,8-diazabicyclo[5.4.0]undec-7-ene. (a) at least one hydroxyl-containing compound, (b) at least one compound having free and/or blocked isocyanate groups, and (c) at least one phosphorus-containing catalyst for the crosslinking of silane groups, (d) at least one further catalyst, one or more constituents of the coating composition containing hydrolyzable silane groups, characterized in that the catalyst is a bicyclic amine and the catalyst is 1,5-diazabicyclo[4.3.0]non-5-ene or 1,8-diazabicyclo[5.4.0]undec-7-ene.
A surgical access retractor for maintaining an enlarged surgical corridor, said retractor having a length sufficient to span from a skin surface through to a region of surgical interest, said retractor having at least one portion shaped to match with the region of surgical interest, wherein the shape of said portion is, at least in part, based on patient specific medical imaging; and characterized in that the retractor comprises at least one first fixation means configured for securing the retractor to a patient's skin.
A substantially purified and/or recombinant antibody comprising: (i) an immunoglobulin heavy chain comprising a variable region comprising an amino acid sequence set forth in SEQ ID NO: 6 or 7 and (ii) an immunoglobulin light chain comprising a variable region comprising an amino acid sequence set forth in SEQ ID NO: 17, wherein the antibody binds human midkine (huMK) protein. (i) an immunoglobulin heavy chain comprising a variable region comprising an amino acid sequence set forth in SEQ ID NO: 6 or 7 and (ii) an immunoglobulin light chain comprising a variable region comprising an amino acid sequence set forth in SEQ ID NO: 17,